Conference Coverage

VIDEO: ‘Spectacular’ results for anakinra in pericarditis


 

AT THE ACR ANNUAL MEETING

References

SAN FRANCISCO – Anakinra might be a life saver for recurrent idiopathic pericarditis when corticosteroids, colchicine, and NSAIDS aren’t working.

Anakinra (Kineret) seemed to end the cycle of recurrent attacks and get patients off corticosteroids in a randomized, placebo-controlled trial from Italy. The drug might even prove to be a steroid-sparing, first-line choice for children.

Investigator Dr. Antonio Brucato of Papa Giovanni XXIII Hospital in Bergamo, Italy, called the results “spectacular.” He explained why in an interview at the annual meeting of the American College of Rheumatology, and also explained exactly how and when to use anakinra for pericarditis.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

aotto@frontlinemedcom.com

Recommended Reading

Leadless pacemaker matches conventional transvenous outcomes
MDedge Internal Medicine
IVUS-guided stent cuts MACE rate
MDedge Internal Medicine
Continuous no better than interrupted chest compressions
MDedge Internal Medicine
VIDEO: Start varenicline during hospitalization for heart attack
MDedge Internal Medicine
AHA: Homemade meals cut type 2 diabetes risk by 13%
MDedge Internal Medicine
AHA: SPRINT’s results upend hypertension targets
MDedge Internal Medicine
Empagliflozin benefited type 2 diabetes patients with CKD
MDedge Internal Medicine
VIDEO: College football linemen develop unwelcome cardiac changes
MDedge Internal Medicine
VIDEO: Study shows how to stand up to the ‘sitting disease’
MDedge Internal Medicine
Starting ACS patients on varenicline in the hospital boosted smoking quit rates
MDedge Internal Medicine